#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-neutrophil cytoplasmic antibody positive vasculitis Mucous membrane pemphigoid Vitamin B12 deficiency Cold type haemolytic anaemia Systemic sclerosis pulmonary Penile squamous cell carcinoma Staphylococcal infection NTRK gene fusion overexpression Thymic carcinoma Hypophosphatasia Monogenic diabetes Herpes simplex Congenital nephrogenic diabetes insipidus Demyelination Primary biliary cholangitis More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Basic Information Mantle cell lymphoma refractory Short-bowel syndrome – Basic Information Breast angiosarcoma metastatic – Life with Disease Nephrotic syndrome – Diagnostics Pituitary-dependent Cushing’s syndrome – Basic Information Phenylketonuria – Life with Disease MELAS syndrome – Treatment Soft tissue sarcoma – Life with Disease Crigler-Najjar syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Danazol Tazemetostat 177Lu-Rhpsma-10.1 L-Lysine Acetate Sar-443579 Nirmatrelvir POTASSIUM CLAVULANATE Ozanimod Irinotecan Hydrochloride VTX-002 Cls12311 Ethinylestradiol RNK001 Azd8421 Hydroxychloroquine Sulfate Gtaexs617 Paclitaxel Tilsotolimod Sodium Arachis Hypogaea Extract Maraviroc More therapies…

    Learn about Your Condition

    Acute leukaemia Erectile dysfunction Polyneuropathy Neuralgia Schizophrenia Malignant melanoma stage II Pleural mesothelioma Suicidal ideation Colitis Vesicoureteric reflux Anaemia of pregnancy Chondrosarcoma Developmental hip dysplasia Myotonic dystrophy IgA nephropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study of Pivmecillinam and Amoxicillin/Clavulanic Acid for Treating Urinary Tract Infections in Patients with Multidrug-Resistant Bacteria

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Ertapenem
    • Pivmecillinam Hydrochloride
    • Sulfamethoxazole
    Sweden

  • Three‑Day versus Seven‑Day Antibiotic Treatment with doxycycline, amoxicillin and ceftriaxone in adults with mild leptospirosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Ceftriaxone
    • Doxycycline
    France

  • Individualized beta‑lactam dosing with piperacillin (drug combination) for ICU patients with sepsis caused by gram‑negative bacteria

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefotaxime
    • Meropenem Trihydrate
    • Piperacillin
    France

  • Intrapleural Alteplase and Dornase Alfa versus VATS for Patients with Pleural Empyema (Parapneumonic Pleural Infection)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infectious pleural effusion
    Investigated Drugs:
    • Dornase Alfa
    • Alteplase
    The Netherlands

  • Study of Doxycycline Bone and Joint Penetration in Patients Undergoing Total Hip Arthroplasty for Hip Osteoarthritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Doxycycline Monohydrate
    • Doxycycline
    France

  • Fosfomycin versus drug combination for oral step‑down treatment of febrile urinary tract infections caused by E. coli in men

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Escherichia urinary tract infection
    Investigated Drugs:
    • Fosfomycin
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    France
Previous Page
1 … 19 20 21 22 23 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!